Inventor

Philip M. Sher

Inventor

Plainsboro, NJ, US

Overview

40→

Patents

1988–2014

Patent span

Chemistry

Primary field (CPC C)

Patents· 40 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds40%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%

C07CAcyclic or carbocyclic compounds13%

A61KPreparations for medical, dental or toiletry purposes11%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%

C07HSugars4%

A61BDiagnosis2%

C07KPeptides1%

C40BCombinatorial chemistry1%

G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data1%

PatentTitleYear

8,815,909'Diaminocyclohexane compounds and uses thereof'2014 8,204,729'Device for predicting and managing blood glucose by analyzing the effect of, and controlling, pharmacodynamic insulin equivalents'2012 7,943,658'Indole indane amide compounds useful as CB2 agonists and method'2011 7,816,357'Azabicyclic heterocycles as cannabinoid receptor modulators'2010 7,670,288'Fluctuating blood glucose notification threshold profiles and methods of use'2010 7,572,808'Triazolopyridine cannabinoid receptor 1 antagonists'2009 7,517,991'N-sulfonylpiperidine cannabinoid receptor 1 antagonists'2009 7,452,892'Triazolopyrimidine cannabinoid receptor 1 antagonists'2008 7,425,550'Lactam glycogen phosphorylase inhibitors and method of use'2008 7,378,418'Azabicyclic heterocycles as cannabinoid receptor modulators'2008 7,365,061'2-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors'2008 7,276,608'Tetrahydroquinoline derivatives as cannabinoid receptor modulators'2007 7,226,942'2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors'2007 7,223,786'2-aminonaphthalene derivatives and related glycogen phosphorylase inhibitors'2007 7,214,704'2-Amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors'2007 7,098,235'Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds'2006 7,057,046'Lactam glycogen phosphorylase inhibitors and method of use'2006 6,936,590'C-aryl glucoside SGLT2 inhibitors and method'2005 6,683,056'O-aryl glucoside SGLT2 inhibitors and method'2004 6,515,117'C-aryl glucoside SGLT2 inhibitors and method'2003 6,436,914'2-hydroxy-3(4-hydroxy-3-sulfonamidophenyl)propylamines useful as beta 3 adrenergic agonists'2002 6,414,126'C-aryl glucoside SGLT2 inhibitors and method'2002 5,827,868'Prostaglandin analogs'1998 5,776,983'Catecholamine surrogates useful as .beta..sub.3 agonists'1998 5,770,615'Catecholamine surrogates useful as .beta..sub.3 agonists'1998 H0001737'7-oxabicycloheptane carboxylic acid prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds and method for preparing same'1998 5,723,489'Aryloxypropanolamine beta 3 adrenergic agonists'1998 5,541,204'Aryloxypropanolamine .beta. 3 adrenergic agonists'1996 5,491,134'Sulfonic, phosphonic or phosphiniic acid .beta..sub.3 agonist derivatives'1996 5,488,064'Benzo 1,3 dioxole derivatives'1996 5,321,036'Thiazole and oxazole-based .beta.3 adrenergic receptor agonists'1994 5,290,799'7-oxabicycloheptyl substituted heterocyclic thioamide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease'1994 5,280,034'Bis-heterocyclic prostaglandin analogs'1994 5,260,449'Method for preparing 7-oxabicycloheptyl substituted bromooxazole amide prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds'1993 5,238,951'Heterocyclic amido prostaglandin analogs'1993 5,153,327'7-Oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease'1992 5,106,991'Geminally substituted thiaheterocyclic carboxylic acids and derivatives thereof'1992 5,100,889'7-oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease'1992 4,975,452'Geminally substituted thiaheterocyclic carboxylic acids and derivatives thereof'1990 4,783,473'Geminally substituted cyclic ether carboxylic acids, derivatives thereof, compositions containing same and method of use'1988

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1988–1998Patents assigned to SQUIBB & SONS INC (10)· patent assignee history

1988–2014Based in Plainsboro, NJ, US· patent location history

1994–2014Patents assigned to BRISTOL MYERS SQUIBB CO (28)· patent assignee history

2010–2014Patents assigned to SHER PHILIP M (2)· patent assignee history

2014Patents assigned to BOLTON SCOTT A (1)· patent assignee history

2014Patents assigned to EWING WILLIAM R (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
BRISTOL MYERS SQUIBB CO	28	1994–2014
SQUIBB & SONS INC	10	1988–1998
SHER PHILIP Mself	2	2010–2014
BOLTON SCOTT A	1	2014
EWING WILLIAM R	1	2014

Locations

Location	Patents	Span
Plainsboro, New Jersey, US	40	1988–2014